Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Saturday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE opened at $0.01 on Friday. The stock has a market cap of $11,350.00, a price-to-earnings ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.